Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Göke

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Der Internist|September 13, 2013
[Diseases in gastroenterology]A Göke, B Göke
Cellular Immunology|June 1, 2000
Regulation of TRAIL-induced apoptosis by transcription factorsR Göke, A Göke, B Göke, et al.
Digestion|October 31, 2001
Pioglitazone inhibits growth of carcinoid cells and promotes TRAIL-induced apoptosis by induction of p21waf1/cip1R Göke, A Göke, B Göke, et al.
The Journal of Experimental Medicine|April 5, 2000
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progressionK Song, Y Chen, R Göke, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Der Internist|September 13, 2013
[Diseases in gastroenterology]A Göke, B Göke
Cellular Immunology|June 1, 2000
Regulation of TRAIL-induced apoptosis by transcription factorsR Göke, A Göke, B Göke, et al.
Digestion|October 31, 2001
Pioglitazone inhibits growth of carcinoid cells and promotes TRAIL-induced apoptosis by induction of p21waf1/cip1R Göke, A Göke, B Göke, et al.
The Journal of Experimental Medicine|April 5, 2000
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progressionK Song, Y Chen, R Göke, et al.
Pageof 1